Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancerCristina Guarducci(Hospital of Prato), Ilenia Migliaccio(Hospital of Prato)npj Breast CancerNovember 22, 201810.1038/s41523-018-0092-4Cited by 134SaveCiteExport RISWatch citationsRelated PapersA gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer|Oncotarget|2016|170Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer|Clinical Cancer Research|2024|34